|
10 Sep 2019 |
Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer’s Patients
|
|
10 Sep 2019 |
ORYZON’s Iadademstat Shows Efficacy Signs in Relapsed SCLC
|
|
10 Sep 2019 |
Recardio's Phase 2 Regenerative Post-Myocardial Infarction Trial of Dutogliptin Now Enrolling and Recruiting in All Global Centers
|
|
10 Sep 2019 |
Neurotrope Announces Top-line Results From Confirmatory Phase 2 Study of Bryostatin-1 in Moderate to Severe Alzheimer's Disease
|
|
10 Sep 2019 |
Merck Initiates Pivotal Phase III Programme for Investigational Evobrutinib in Relapsing Multiple Sclerosis
|
|
10 Sep 2019 |
Updated Results for Investigational Therapy Tepotinib Presented at WCLC 2019
|
|
10 Sep 2019 |
Cyclacel Pharmaceuticals Announces First Patient Treated With Oral CYC065 in a Phase 1 Study in Patients With Advanced Solid Tumors
|
|
09 Sep 2019 |
Theravance Biopharma Reports Positive Results from Phase 1 Clinical Trial of TD-8236, an Investigational, Lung-Selective, Inhaled Pan-Janus Kinase (JAK) Inhibitor for Inflammatory Lung Diseases
|
|
09 Sep 2019 |
New Data from Esketamine Nasal Spray Phase 3 Studies Showed Rapid Reduction of Depressive Symptoms in Adult Patients with Major Depressive Disorder Who Have Active Suicidal Ideation with Intent
|
|
09 Sep 2019 |
Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA
|
|
09 Sep 2019 |
ACADIA Pharmaceuticals Announces Pivotal Phase 3 HARMONY Trial Stopped Early for Positive Efficacy as Pimavanserin Meets the Primary Endpoint in Patients with Dementia-Related Psychosis
|
|
09 Sep 2019 |
New Preclinical Research Suggests Tetra Therapeutics’ BPN14770 Protects Against Memory Loss and Neuronal Atrophy in Alzheimer’s Disease
|
|
09 Sep 2019 |
MicuRx Pharmaceuticals Reports Positive Top-Line Results From a US Phase 2 ABSSSI Clinical Trial of Novel Antibiotic Contezolid Acefosamil
|
|
09 Sep 2019 |
Ipsen and Servier announce initial Phase II/III clinical data evaluating investigational liposomal irinotecan (ONIVYDE®) as a second-line treatment for small cell lung cancer (SCLC) at the IASLC 2019 World Conference on Lung Cancer
|
|
09 Sep 2019 |
Lilly Announces Positive Results for Selpercatinib (LOXO-292), Demonstrating a 68 Percent Objective Response Rate and Sustained Durability in Heavily Pretreated RET Fusion-Positive Non-Small Cell Lung Cancer
|
|
08 Sep 2019 |
Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Larger Patient Group At WCLC 2019
|
|
07 Sep 2019 |
FDA approves Ofev® as the first and only therapy to slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated ILD
|
|
06 Sep 2019 |
Novartis investigational lung cancer therapy capmatinib (INC280) granted FDA Breakthrough Therapy Designation for patients with MET-mutated advanced non-small cell lung cancer
|
|
06 Sep 2019 |
LONSURF® (trifluridine/tipiracil) Receives Marketing Authorization in Europe for Patients With Previously Treated Metastatic Gastric Cancer
|
|
06 Sep 2019 |
Selvita Announces First Patient Dosed in Phase 1b Study of CDK8 Inhibitor SEL120 in the Treatment of Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
|
|
05 Sep 2019 |
GBT Announces U.S. Food and Drug Administration Acceptance of New Drug Application and Priority Review for Voxelotor for the Treatment of Sickle Cell Disease
|
|
05 Sep 2019 |
Applied Therapeutics Announces Initiation of Phase 3 Registrational Trial of AT-001 in Diabetic Cardiomyopathy (ARISE-HF)
|
|
05 Sep 2019 |
Idera Pharmaceuticals Announces Immuno-Oncology Clinical Research Collaboration with AbbVie
|
|
05 Sep 2019 |
Aduro Biotech Announces First Patient Dosed in Phase 2 Study of ADU-S100 (MIW815) in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
|
|
05 Sep 2019 |
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson’s Disease and Launch of Its Engage Parkinson’s Website
|
